Neurofeedback as a Treatment for Trauma-affected Refugees
Exploring the Feasibility of Neurofeedback for Trauma-affected Refugees - a Qualitative Study
1 other identifier
interventional
32
1 country
1
Brief Summary
Neurofeedback (NF) is a form of treatment that can assist individuals in learning to control their brain wave activity. NF-studies have shown promising results in reducing PSTD-symptoms among military veterans, but there are no published peer-reviewed studies with refugees. However, preliminary studies from Malmö and Sydney indicate that refugees could benefit from NF. Therefore, at the Competence Centre for Transcultural Psychiatry (CTP) a longitudinal feasibility study, testing NF for trauma-affected was started. The study contains both a quantitative and a qualitative substudy. In in the quantitative substudy, where a total of 32 participants have been included, the aim was to evaluate the feasibility of NF with trauma affected refugees using a quantitative perspective. The NF intervention offered was 12 training sessions of 12-20 minutes NF, and the outcome measures were self-administered questionnaires and semi-structured interviews collected before and after the intervention. In a subsample of eight participants of those included in the quantitative substudy, qualitative in-depth interviews were carried out. The participants were offered two interviews; one before the first NF training and one during the treatment course. The aim of the qualitative substudy was to evaluate the feasibility of NF with trauma-affected refugees by examining the participants' thoughts and expectations prior to participating in NF treatment as well as their experience with the treatment after a few sessions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Nov 2018
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 22, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 13, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
March 13, 2020
CompletedFirst Submitted
Initial submission to the registry
July 26, 2021
CompletedFirst Posted
Study publicly available on registry
September 23, 2021
CompletedSeptember 23, 2021
July 1, 2021
1.3 years
July 26, 2021
September 14, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Harvard Trauma Questionnaire (HTQ)
Change in PTSD symptoms measured by the first 16 items in the Harvard Trauma Questionnaire
Baseline and after 12 weeks
Secondary Outcomes (5)
Hopkins Symptom Checklist-25 (HSCL-25)
Baseline and after 12 weeks
Sheehan Disability Scale (SDS)
Baseline and after 12 weeks
WHO-Five Well-being Index (WHO-5)
Baseline and after 12 weeks
Hamilton interview-based rating scales for depression (Ham-D) and anxiety (Ham-A)
Baseline and after 12 weeks
Satisfaction and Accept-ability Questionnaire (SAQ)
After 12 weeks
Interventions
In neurofeedback (NF), the brainwave activity is measured by an electro-encephalography and fed back to the person as an auditory or visual signal, rewarding the person each time progress is made toward normalizing dysregulated neural activity. The learning mechanism is at its base considered to be operant conditioning, where the behavior of the participant-in this case, neurological activity-is gradually changed through repeated reinforcement. In neurofeedback, this simple learning mechanism is accelerated by continuous and instant feedback, with rewards occurring as often as every second. The NF intervention included 12 NF training sessions, one session per week, off approximately 12-20 min. The protocol was a replicate of the setup of recent NF studies investigating NF as a treatment for chronic PTSD. The feedback was based on a single channel recording, rewarding brainwave frequencies associated with a calm and relaxed state and inhibiting drowsiness and hyperarousal.
Eligibility Criteria
You may qualify if:
- Refugee or a person who had been family reunified with a refugee
- Diagnosed with PTSD (ICD-10 diagnosis F43.1) and experienced a psychological trauma in another country than Denmark.
- Informed consent.
You may not qualify if:
- Current abuse of drug or alcohol (F1x.24-F1x.26)
- Diagnosed with a severe psychotic disorder (F2x) or a manic disorder (F30.1-F31.9).
- No informed consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mental Health Centre Copenhagen, Bispebjerg and Frederiksberg Hospitallead
- Lundbeck Foundationcollaborator
- Jascha Fondencollaborator
Study Sites (1)
Competence Centre for Transcultural Psychiatry
Ballerup Municipality, 2750, Denmark
Related Publications (1)
Hannemose SZ, Laugesen Attardo H, Vindbjerg E, Carlsson J. Exploring expectations of neurofeedback treatment among trauma-affected refugees. Nord J Psychiatry. 2024 Jan;78(1):46-53. doi: 10.1080/08039488.2023.2261905. Epub 2024 Jan 8.
PMID: 37755151DERIVED
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sigrid Z Hannemose, MD
Competence Centre for Transcultural Psychiatry
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- DEVICE FEASIBILITY
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 26, 2021
First Posted
September 23, 2021
Study Start
November 22, 2018
Primary Completion
March 13, 2020
Study Completion
March 13, 2020
Last Updated
September 23, 2021
Record last verified: 2021-07